| Business Summary | | Novitron
International,
Inc.
is
a
multinational
corporation
that
produces
scientific
instrumentation
used
in
medical,
veterinary,
and
analytical
laboratories
and
in
industrial
process
monitoring.
The
Company's
Dutch
subsidiary,
Vital
Scientific
NV,
designs
and
manufactures
scientific
and
clinical
laboratory
instrumentation
marketed
worldwide
through
distributors
and
strategic
partnerships.
The
Company's
Australian
subsidiary,
Vital
Diagnostics
Pty.
Ltd.,
distributes
diagnostic
instruments
and
assays
in
the
South
Pacific
and
has
entered
into
a
strategic
alliance
with
Medical
Innovations
Limited
for
the
development
of
immunoassay
diagnostics.
The
Company's
Dutch
subsidiary,
NovaChem
BV,
develops
and
markets
process
monitors
with
applications
in
petrochemical
and
pharmaceutical
production
and
in
environmental
monitoring. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Novitron
International,
Inc.
designs,
manufactures
and
markets
scientific
instrumentation
used
in
medical,
veterinary,
and
analytical
laboratories
and
in
industrial
process
monitoring.
For
the
fiscal
year
ended
3/31/01,
revenues
decreased
9%
to
$12.9
million.
Net
income
totalled
$403
thousand,
up
from
$108
thousand.
Revenues
reflect
lower
HYTEC
288
and
Selectra
by
Vital
Scientific
sales.
Earnings
were
offset
by
the
absence
of
a
$75
thousand
restructuring
charge. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
2,959;
after
tax
earnings
were
76. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Israel Stein, M.D., 57 Chairman,
Pres, CEO and Treasurer | $185K | -- | Emile Hugen, 55 Managing
Director of Vital Scientific NV | 89K | -- | Adrian Tennyenhuis, 49 Sr.
VP | 123K | $13K | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|